SIVIGILA
Cross-source consensus on SIVIGILA from 1 sources and 4 claims.
1 sources · 4 claims
Evidence quality
Where it comes from
Highlighted claims
- The cohort records came from SIVIGILA managed by Medellín's Secretary of Health. — Survival and factors associated with mortality among people with tuberculosis in Medellín, Colombia (2018–2023): a retrospective cohort study
- Fragmentation in SIVIGILA prevented analysis of drug resistance, adherence, and complete comorbidity profiles at the individual level. — Survival and factors associated with mortality among people with tuberculosis in Medellín, Colombia (2018–2023): a retrospective cohort study
- Administrative surveillance data limited follow-up and the variable set available for analysis. — Survival and factors associated with mortality among people with tuberculosis in Medellín, Colombia (2018–2023): a retrospective cohort study
- Pandemic boundary misclassification was possible but likely had minimal impact because of the population size. — Survival and factors associated with mortality among people with tuberculosis in Medellín, Colombia (2018–2023): a retrospective cohort study